The effect of having an affected parent or sibling on invasive and in situ skin cancer risk in Sweden
- PMID: 19242514
- DOI: 10.1038/jid.2009.31
The effect of having an affected parent or sibling on invasive and in situ skin cancer risk in Sweden
Abstract
Studies suggest that skin cancer aggregates within families; however, the risk of skin cancer associated with having an affected sibling or parent by subtype, tumor site, and age at diagnosis has not been established. The 2006 update of the Swedish Family-Cancer Database was used to calculate standardized incidence ratios (SIRs), representing the ratio of cancer risk among individuals with affected parents or siblings to the general population. Risk of invasive squamous cell skin cancer for individuals with an affected sibling or parent was increased between two- and three-fold compared with that in the general population. For in situ skin tumors, increased SIRs of 1.95-4.30 for squamous cell, Bowen's disease, and actinic keratosis were observed for individuals with affected siblings or parents, and SIRs were generally higher for tumors at sun-exposed versus covered sites. Finally, SIRs for in situ and invasive squamous cell skin cancer increased by increasing number of parental tumors (P< or =0.01). In conclusion, having an affected sibling or parent was associated with an increased risk of skin cancer of varied subtypes compared with that in the general population, and for some subtypes, these familial risks were increased for tumors at sun-exposed sites or by an increasing number of parental tumors.
Similar articles
-
Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.Int J Cancer. 2003 May 10;104(6):764-71. doi: 10.1002/ijc.10976. Int J Cancer. 2003. PMID: 12640685
-
[Squamous cell carcinoma, basalioma and Bowen's disease associated with porokeratosis of Mibelli].Nihon Hifuka Gakkai Zasshi. 1982 Sep;92(10):1061-4. Nihon Hifuka Gakkai Zasshi. 1982. PMID: 6985287 Japanese. No abstract available.
-
Time trends and familial risks in squamous cell carcinoma of the skin.Arch Dermatol. 2003 Jul;139(7):885-9. doi: 10.1001/archderm.139.7.885. Arch Dermatol. 2003. PMID: 12873883
-
Bowen's disease (squamous cell carcinoma in situ) as a skin marker for internal malignancy: a case-control study.Am J Prev Med. 1990 Jul-Aug;6(4):238-43. Am J Prev Med. 1990. PMID: 2223171 Review.
-
Arsenic carcinogenesis in the skin.J Biomed Sci. 2006 Sep;13(5):657-66. doi: 10.1007/s11373-006-9092-8. Epub 2006 Jun 29. J Biomed Sci. 2006. PMID: 16807664 Review.
Cited by
-
Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk.J Invest Dermatol. 2018 Jul;138(7):1507-1510. doi: 10.1016/j.jid.2018.01.031. Epub 2018 Feb 13. J Invest Dermatol. 2018. PMID: 29452120 Free PMC article.
-
Management of a cutaneous squamous cell carcinoma overlying an AV fistula.BMJ Case Rep. 2017 May 6;2017:bcr2016218932. doi: 10.1136/bcr-2016-218932. BMJ Case Rep. 2017. PMID: 28478388 Free PMC article.
-
Differences of clinical features, prognosis and genetic mutations in Chinese patients with malignant melanoma and additional primary tumours.Ann Med. 2025 Dec;57(1):2493769. doi: 10.1080/07853890.2025.2493769. Epub 2025 May 3. Ann Med. 2025. PMID: 40317239 Free PMC article.
-
Comparison of Familial Clustering of Anogenital and Skin Cancers Between In Situ and Invasive Types.Sci Rep. 2019 Nov 6;9(1):16151. doi: 10.1038/s41598-019-51651-6. Sci Rep. 2019. PMID: 31695117 Free PMC article.
-
Identification of Genetic Risk Factors for Keratinocyte Cancer in Immunosuppressed Solid Organ Transplant Recipients: A Case-Control Study.Cancers (Basel). 2023 Jun 26;15(13):3354. doi: 10.3390/cancers15133354. Cancers (Basel). 2023. PMID: 37444464 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical